Editorial
Volume 4 Issue 8 - 2020
Why a Stress Protein, HDFx, May be Useful as an Ameliorative in the Treatment of “Cytokine Storms”, Depression in Cardiac Hemodynamics and Coagulopathies in Coronavirus Diseases Such as COVID-19, SARS, and MERS
Burton M Altura1-4*, Asefa Gebrewold1,3 and Anthony Carella1
1Department of Physiology and Pharmacology, The State University of New York Downstate Medical Center, Brooklyn, New York, USA
2The School of Graduate Studies in Molecular and Cellular Science, The State University of New York Downstate Medical Center, Brooklyn, New York, USA
3Bio-Defense Systems, Inc, Rockville Centre, New York, USA
4Orient Biomedica, Estero, Florida, USA
*Corresponding Author: Burton M Altura, Professor, Department of Physiology and Pharmacology, The State University of New York Downstate Medical Center, Brooklyn, New York, USA.
Received: June 27, 2020; Published: July 29, 2020




Introduction

Recently, it has been found that diseases produced by coronaviruses (i.e. COVID-19, SARS, MERS, etc.) present with a growing array of symptoms, including high fevers, coagulopathies, depression in cardiac hemodynamics, and cytokine storms, among other characteristic signs [1-7]. If, however, these four pathophysiological signs could be attenuated, significantly, we believe the course of the coronaviral pathologies could be lessened, particularly in the lungs and probably result in far less deaths, less hospitalization, less hospital costs, and much faster recoveries.

References

  1. Perlman S and Danderkar AA. “Immunopathogenesis of coronavirus infections: implications for SARS”. Nature Reviews Immunology 12 (2005): 917-927.
  2. Fung TS and Liu DX. “Coronavirus infection, ER stress, apoptosis and innate immunity”. Frontiers in Microbiology (2014).
  3. Kim ES., et al. “Clinical progression and cytokine profile of Middle East respiratory syndrome coronavirus infection”. Journal of Korean Medical Science 31 (2016): 1717-1725.
  4. Killerby ME and Bigs HM. “Middle East respiratory syndrome coronavirus transmission”. Emerging Infectious Diseases 2 (2020): 191-208.
  5. Li Q., et al. “Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia”. The New England Journal of Medicine 382 (2020): 1199-1207.
  6. Kikkert M. “Innate immune evasion by human respiratory RNA viruses”. The Journal of Innate Immunity 1 (2020): 4-20.
  7. Kimura H., et al. “Cytokine production and signaling pathways in respiratory virus infection”. Frontiers in Microbiology 4 (2013): 276.
  8. Altura BM., et al. “A novel biologic immunomodulator, HFDx, protects against lethal hemorrhage, endotoxins, and traumatic injury: potential relevance to emerging diseases”. International Journal of Clinical and Experimental Medicine 3 (2009): 266-279.
  9. Altura BM., et al. “HDFx: A novel biologic immunomodulator is therapeutically effective in hemorrhage and intestinal ischemic shock: importance of microcirculatory-immunological interactions and their implications for the warfighter and disaster victims”. International Journal of Clinical and Experimental Medicine 4 (2011): 331-340.
  10. Altura BM., et al. “HDFX: A novel biologic immunomodulator accelerates wound healing and is suggestive of unique regenerative powers: potential implications for the warfighter and disaster victims”. International Journal of Clinical and Experimental Medicine 4 (2012): 285-295.
  11. Altura BM. “Role of reticuloendothelial and endothelial cells in response to shock and trauma”. In: Pathophysiology of Combined Injuries and Trauma, Conklin JT, ed. University Park Press, Baltimore (1985).
  12. Altura BM. “Endothelial and reticuloendothelial cell function in injury and low flow states”. In: The Scientific Basis for the Care of the Clinically Ill, Little RA, Frayn KN, editions. Manchester Univ Press, Manchester, The UK (1986): 259-274.
  13. Altura BM., et al. “HDFx: A novel immunomodulator and potential fighter against cytokine storms in inflammatory and septic conditions in dogs and farm animals”. International Journal of Veterinary Health Science and Research 2 (2017): 1-3.
  14. Altura BM., et al. “HDFx: A stress-induced biologic that inhibits and reverses endotoxin-induced fevers and depression in cardiac hemodynamics in rabbits, guinea-pigs and rats: Potential relevance to coronal fevers and role of NF-kB”. The Journal of Clinical and Experimental Cardiology 4 (2020): e654.
  15. Halevy S., et al. “HDFx: A biologic ameliorates deep vein thrombosis in two rodent animal models: In-vivo microcirculatory studies and relation to human DVT”. Annals of Vascular Medicine and Research 3 (2020): 1112.
  16. Hershey SG and Altura BM. “Effects of pretreatment with aggregate human albumin on the reticuloendothelial system activity and after experimental shock”. Proceedings of The Society for Experimental Biology and Medicine 122 (1966): 1195-1199.
  17. Altura BM., et al. “Microcirculatory approach to vasopressor therapy in intestinal ischemic (SMA) shock”. The American Journal of Surgery 111 (1966): 186-192.
  18. Altura BM and Hershey SG. “Use of reticuloendothelial phagocytic as an index in shock therapy”. The bulletin of the New York Academy of Medicine 43 (1967): 259-266.
  19. Altura BM and Hershey SG. “RES phagocytic function in trauma and adaptation to experimental shock”. American Journal of Physiology 215 (1968): 1414-1419.
  20. Altura BM and Hershey SG. “Influence of vasopressor drugs on reticuloendothelial phagocytic function in experimental shock”. In: Intermedes Proceedings Combined Injuries and Shock. Almqvist and Wiksell, Stockholm (1968): 185-193.
  21. Hershey SG and Altura BM. “Influence of RES stimulating materials compatible for man on phagocytosis after experimental shock”. In: Intermedes Proceedings Combined Injuries and Shock. Almqvist and Wiksell, Stockholm (1968): 195-209.
  22. Altura BM and Hershey SG. “Patterns of RES phagocytic function in trauma and experimental adaptation to shock”. In: Intermedes Proceedings 1968; Combined Injuries and Shock. Almqvist and Wiksell, Stockholm (1968): 205-213.
  23. Hershey SG and Altura BM. “Function of the reticuloendothelial in experimental shock and combined injury”. Anesthesiology 30 (1969): 138-143.
  24. Hershey SG and Altura BM. “The effects of vasoactive drugs on reticuloendothelial function in experimental shock and combined injury”. Anesthesiology 30 (1969): 144-149.
  25. Altura BM and Hershey SG. “Effects of glyceryl trioleate on the reticuloendothelial system and after experimental shock”. Journal of Pharmacology and Experimental Therapeutics 175 (1970): 555-564.
  26. Altura BM., et al. “Microcirculatory actions of vasoactive polypeptides and their use in the treatment of experimental shock”. In: Advances in Experimental Medicine and Biology, Bradykinin and Related Kinins: Cardiovascular, Biochemical and Neural Actions, Sicuteri F, Rocha e Silva M, Back N. Plenum Press, New York 8 (1970): 239-247.
  27. Altura BM and Hershey SG. “Acute intestinal ischemia shock and reticuloendothelial system function”. Journal of the Reticuloendothelial Society 10 (1971): 361-371.
  28. Altura BM and Hershey SG. “Sequential changes in reticuloendothelial system function after acute hemorrhage”. Proceedings of The Society for Experimental Biology and Medicine 139 (1972): 935-939.
  29. Altura BM. “Structure-activity relationships of neurohypohyseal polypeptides on different types of isolated mammalian blood vessels”. In: Advances in Experimental Medicine and Biology, Vasopeptides: Chemistry, Pharmacology and Pathophysiology, Back N, Sicuteri F, eds. Plenum Press, New York 21 (1972): 187-196.
  30. Altura BM and Hershey SG. “A structure-activity basis for vasotropic peptide therapy in shock”. In: Advances in Experimental Medicine and Biology, Vasopeptides: Chemistry, Pharmacology and Pathophysiology, Back N, Sicuteri F, ed. Plenum Press, New York 21 (1972): 399-408.
  31. Altura BM and Hershey SG. “Reticuloendothelial function in experimental injury and tolerance to shock”. In: Advances in Experimental Medicine and Biology, Neuro-Humoral and Metabolic Aspects of Injury, Kovach AGB, ed. Plenum Press, New York 33 (1973): 545-569.
  32. Altura BM and Altura BT. “Peripheral vascular effects of glucocorticoids and their relationship to protection in circulatory shock”. Journal of Pharmacology and Experimental Therapeutics 190 (1974): 300-315.
  33. Halevy S and Altura BM. “Genetic factors influencing resistance to trauma”. Circulatory Shock 1 (1974): 287-293.
  34. Altura BM. “Hemorrhagic shock and reticuloendothelial system function in pathogen-free animals”. Circulatory Shock 1 (1974): 295-300.
  35. Altura BM and Altura BT. “Pharmacodynamic actions of corticosteroids on microcirculation and vascular smooth muscle”. In: Steroids and Shock, Glenn TH, ed. University Park Press, Baltimore (1974): 67-88.
  36. Altura BM. “DPAVP: A vasopressin analog with selective microvascular and RES actions for the treatment of circulatory shock in rats”. European Journal of Pharmacology 37 (1976): 155-168.
  37. Altura BM. “Microcirculatory approach to the treatment of circulatory shock using a new analog of vasopressin, [2-phenylalanine, 8-ornithine]-vasopressin”. Journal of Pharmacological 198 (1976): 187-196.
  38. Altura BM. “Sex and estrogens in protection against circulatory stress reactions”. American Journal of Physiology 231 (1976): 187-196.
  39. Altura BM. “Reticuloendothelial and neuro-endocrine stimulation in shock therapy”. Advances in Shock Research 3 (1980): 3-25.
  40. Altura BM. “Reticuloendothelial and neuro-endocrine stimulation”. The Journal of Clinical Anesthesia 4 (1980): 745-758.
  41. Altura BM. “Adv in Microcirculation” 11 (1980): 77-113.
  42. Altura BM and Saba TM. “Pathophysiology of the Reticuloendothelial System”. Raven Press, New York.
  43. Halevy S., et al. “Pathophysiological basis for the use of steroids for the treatment of shock and trauma”. Wiener Klinische Wochenschrift 60 (1982): 1621-1630.
  44. Altura BM. “Reticuloendothelial system function and histamine release in shock and trauma”. Wiener Klinische Wochenschrift 60 (1982): 282-290.
  45. Altura BM. “Microcirculatory regulation and dysfunction: Relation to RES function”. In: The Reticuloendothelial System, Reichard SM, Filkins JP, ed. Plenum Press, New York 7 (1985): 355-393.
  46. Altura BM., et al. “Synthetic vasopressin and oxytocin analogs and their potential use in hemorrhagic, traumatic and septic shock: A personal perspective”. International Journal of Surgery Research 3 (2017): 1-3.
  47. Altura BM., et al. “Why synthetic vasopressin and oxytocin analogs should be considered in the treatment of cardiogenic shock: A personal perspective”. Clinics in Surgery 1 (2018): 19-23.
  48. Metchnikoff E. “Investigations of intracellular digestion in invertebrates”. Arb Zool Inst Wien 5 (1883): 141-168.
  49. Zweifach BW and Thomas L. “The relationship between the vascular manifestations of shock produced by endotoxin, trauma, and hemorrhage”. Journal of Experimental Medicine 3 (1957): 385-401.
  50. Zweifach BW. “The contribution of the reticuloendothelial system to experimental shock”. Annals of the New York Academy of Sciences 1 (1960): 203-212.
  51. Majno G and Joris I. “Cells, Tissues, and Diseases, 2nd Edition”. Oxford University Press (2004).
  52. Washington K. “Inflammatory and infectious diseases of the liver”. In: Gastrointestinal and Liver Pathology. Incubuzio C, Ed. Churchill-Livingston, London (2005).
  53. Rehermann B. “Natural killer cells in viral hepatitis”. Cellular and Molecular Gastroenterology and Hepatology 6 (2015): 578-588.
  54. Murphy K and Weaver C. “Janeway’s Immunology”. Garland Press, New York (2018) 10th
  55. Ackermann M., et al. “Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19”. The New England Journal of Medicine (2020).
  56. Shen C., et al. “Treatment of 5 critically ill patients with COVID-19 with convalescent plasma”. The Journal of the American Medical Association (2020).
Citation: Burton M Altura., et al. “Why a Stress Protein, HDFx, May be Useful as an Ameliorative in the Treatment of “Cytokine Storms”, Depression in Cardiac Hemodynamics and Coagulopathies in Coronavirus Diseases Such as COVID-19, SARS, and MERS”. EC Emergency Medicine and Critical Care 4.8 (2020): 92-97.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


October Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the October issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before November 08, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk